VeriSIM Life Named “Predictive Analytics Solution of the Year” by BioTEch Breakthrough

VeriSIM Life, a Serra portfolio company in Serra III and SBIC, made an exciting announcement the first week of November that they had received the honor of being named “Predictive Analytics Solution of the Year” in this year’s BioTech Breakthrough Awards. Biotech Breakthrough is a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products, and services around the globe.

VeriSIM Life is the leading artificial intelligence (AI)-enabled unique R&D decisions de-risker for breakthrough drug development. "We are honored to receive this award from BioTech Breakthrough,” said Dr. Jo Varshney, CEO of VeriSIM Life. “Being named Predictive Analytics Solution of the Year validates our recent BIOiSIM platform innovations. Technologies like our unique Translational Index™, which synthesizes the potential for clinical success of any drug candidate, enable smarter decisions about how to advance asset programs and ultimately improve the lives of patients in need.”

View the entire article here.